Scenario
Please read this scenario prior to answering the Question You are serving as the Lead Architect for
an enterprise architecture project team within a leading multinational pharmaceutical and medical
devices manufacturer. Its brands include numerous household names for medications and first aid
supplies. The company has a long history of innovating new treatments for many common illnesses
and diseases. Prior to launching a new treatment, the company has to demonstrate Its effectiveness
and safety in a set of clinical trials that satisfy the regulatory requirements of the countries in the
target markets. All clinical trials are undertaken by its research laboratories, which employ over
10,000 people at separate facilities in the United Kingdom, United States, Sweden, France, Canada,

India, China and Japan. In addition to internal research and development activities the company is
also involved in publicly funded collaborative research projects, with other industrial and academic
partners. The Enterprise Architecture group within the company has been engaged in an
architecture development project to create a secure networked collaboration system that will allow
researchers at its product development laboratories worldwide to share information about their
clinical trials. This system will also connect with external partners. The Enterprise Architecture group
within the company has been engaged in an architecture development project to create a secure
networked collaboration system that will allow researchers at its product development laboratories
worldwide to share information about their clinical trials. This system will also connect with external
partners. The Enterprise Architecture group is a mature organization. They use the TOGAF 9 ADM
with extensions required to support current good manufacturing practices and good laboratory
practices in their target markets. Due to the highly sensitive nature of the information that is
managed, special care was taken to ensure that each architecture domain included an examination
of the security and privacy issues that are relevant. The Executive Vice President for Clinical Research
is the sponsor of the Enterprise Architecture activity. She has stated that the changes to the
enterprise architecture for the new system will need to be rolled out in stages on a regional basis
that minimizes disruptions to ongoing clinical trials. Refer to the Scenario You have been asked to
recommend the approach to identify the work packages that will be included in the Transition
Architecture(s). Based on TOGAF, which of the following is the best answer?

Scenario
Please read this scenario prior to answering the Question You are serving as the Lead Architect for
an insurance company, which has been formed through the merger of three previously independent
companies. The company now consists of three divisions with the same names and division
headquarters as their predecessors. The lack of integration between the three divisions has
increasingly caused problems in the handling of customer and financial information. The inability to
share information has resulted in lost opportunities to leverage the synergies that should have been
possible as a result of the merger. At present, each division maintains its own applications. Despite
an earlier initiative to install a common application to manage customer, products, and claims
information, each division has different ways of defining these core elements and has customized
the common application to the point where the ability to exchange information is difficult, costly,
and error-prone. As a result, the company has made the decision to introduce a common web portal,
contact center software suite, and document management system. Also the company has selected a
single enterprise-wide customer relationship management (CRM) application to consolidate
information from several applications that exist across the divisions. The application will be used by
each of the divisions and accessed by third party partners through well defined interfaces. The
Corporate Board is concerned that the new application must be able to manage and safeguard
confidential customer information in a secure manner that meets or exceeds the legal requirements
of the countries in which the company operates. This will be an increasingly important capability as
the company expands its online services in cooperation with its partners. The CIO has formed an
Enterprise Architecture department, and one of the primary goals in its charter is to coordinate
efforts between the implementation team and the migration teams in each division. The CIO has
also formed a cross-functional Architecture Board to oversee and govern the architecture. The
company has an existing team of security architects. TOGAF 9 has been selected as the core
framework for use for the Enterprise Architecture program. The CIO has endorsed this choice with
the full support of top management. Refer to the Scenario As part of the process for establishing the
Enterprise Architecture department; you are developing a set of architecture principles to guide the
activities. You need to recommend the best approach for this work. Based on TOGAF, which of the
following is the best answer?